Blood test could predict melanoma treatment failure early
NCT ID NCT04866680
First seen Feb 11, 2026 · Last updated May 25, 2026 · Updated 15 times
Summary
This study looks at whether a simple blood test can help doctors track melanoma and spot when a treatment stops working. About 136 adults with stage IIB to IV melanoma will give blood samples over time. The goal is to see if changes in tumor DNA in the blood can predict the need to switch treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CGFL
Dijon, France
-
CHU Jean Minjoz
Besançon, France
-
Chru Lille
Lille, France
-
Chru Nancy
Vandœuvre-lès-Nancy, France
-
Chu Dijon
Dijon, France
-
Ghr Mulhouse Sud Alsace
Mulhouse, France
-
Institut Godinot
Reims, 51100, France
-
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
Conditions
Explore the condition pages connected to this study.